Related references
Note: Only part of the references are listed.Disease-modifying drugs for multiple sclerosis in pregnancy A systematic review
Ellen Lu et al.
NEUROLOGY (2012)
Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment
Kerstin Hellwig et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Natalizumab Drug Holiday in Multiple Sclerosis: Poorly Tolerated
Joep Killestein et al.
ANNALS OF NEUROLOGY (2010)
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement
S. Vukusic et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis
Judith Haas et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis
A Achiron et al.
JOURNAL OF NEUROLOGY (2004)
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse
S Vukusic et al.
BRAIN (2004)
Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis
J de Seze et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
A controlled trial of natalizumab for relapsing multiple sclerosis.
DH Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
